INVO Bioscience, Inc.
INVO
$2.00
$0.179.29%
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 942.90K | 475.10K | 232.40K | 1.06M | 112.50K |
Total Receivables | 257.20K | 176.90K | 140.60K | 116.80K | 74.90K |
Inventory | 250.10K | 266.50K | 264.50K | 254.20K | 280.00K |
Prepaid Expenses | 945.90K | 806.50K | 622.30K | 365.20K | 374.70K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 2.40M | 1.72M | 1.26M | 1.79M | 842.10K |
|
|||||
Total Current Assets | 2.40M | 1.72M | 1.26M | 1.79M | 842.10K |
Net Property, Plant & Equipment | 3.06M | 3.78M | 6.57M | 6.63M | 4.66M |
Long-term Investments | 5.88M | 5.88M | 5.88M | 8.22M | -- |
Goodwill | 5.88M | 5.88M | 5.88M | 8.22M | -- |
Total Other Intangibles | 3.68M | 3.89M | 4.09M | 1.75M | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 18.03M | 18.32M | 20.89M | 19.48M | 6.64M |
|
|||||
Total Accounts Payable | 2.38M | 2.80M | 2.33M | 1.85M | 1.84M |
Total Accrued Expenses | 646.80K | 766.20K | 722.30K | 590.60K | 1.20M |
Short-term Debt | 1.46M | 1.68M | 1.51M | 880.00K | 1.03M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 237.00K | 352.60K | 397.60K | 1.21M | 227.00K |
Total Finance Division Other Current Liabilities | 3.27M | 3.36M | 3.26M | 353.40K | 161.20K |
Total Other Current Liabilities | 3.27M | 3.36M | 3.26M | 353.40K | 161.20K |
Total Current Liabilities | 7.99M | 8.96M | 8.22M | 4.88M | 4.47M |
|
|||||
Total Current Liabilities | 7.99M | 8.96M | 8.22M | 4.88M | 4.47M |
Long-Term Debt | 1.17M | 1.21M | 1.25M | 1.10M | -- |
Short-term Debt | 1.46M | 1.68M | 1.51M | 880.00K | 1.03M |
Capital Leases | 2.51M | 3.14M | 5.52M | 5.62M | 3.87M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 5.00M | 5.00M | 5.00M | 7.50M | 1.90K |
Total Liabilities | 16.67M | 18.31M | 20.00M | 19.10M | 8.34M |
|
|||||
Common Stock & APIC | 55.77M | 52.92M | 52.71M | 56.20M | 52.87M |
Retained Earnings | -61.91M | -59.41M | -57.82M | -55.82M | -54.57M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -6.14M | -6.49M | -5.11M | 372.80K | -1.71M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 7.51M | 6.50M | 6.00M | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 7.51M | 6.50M | 6.00M | -- | -- |
|
|||||
Total Common Equity | -6.14M | -6.49M | -5.11M | 372.80K | -1.71M |
Total Preferred Equity | 7.51M | 6.50M | 6.00M | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1.36M | 10.20K | 892.80K | 372.80K | -1.71M |
|